iBio, Inc. (IBIO)
1.475
+0.06
(+3.87%)
USD |
NASDAQ |
Aug 25, 16:00
1.475
0.00 (0.00%)
After-Hours: 16:33
iBio Debt to Equity Ratio : 0.03 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.03 |
| December 31, 2025 | 0.0433 |
| September 30, 2025 | 0.0588 |
| June 30, 2025 | 0.2358 |
| March 31, 2025 | 0.3396 |
| December 31, 2024 | 0.2988 |
| September 30, 2024 | 0.2496 |
| June 30, 2024 | 0.2092 |
| March 31, 2024 | 0.6972 |
| December 31, 2023 | 1.791 |
| September 30, 2023 | 1.257 |
| June 30, 2023 | 1.110 |
| March 31, 2023 | 1.034 |
| December 31, 2022 | 1.084 |
| September 30, 2022 | 0.5517 |
| June 30, 2022 | 0.4059 |
| March 31, 2022 | 0.3498 |
| December 31, 2021 | 0.3058 |
| September 30, 2021 | 0.3544 |
| June 30, 2021 | 0.3013 |
| March 31, 2021 | 0.3117 |
| December 31, 2020 | 0.3052 |
| September 30, 2020 | 0.4101 |
| June 30, 2020 | 0.5812 |
| March 31, 2020 | 8.466 |
| Date | Value |
|---|---|
| December 31, 2019 | -63.36 |
| September 30, 2019 | -16.75 |
| June 30, 2019 | 10.10 |
| March 31, 2019 | 3.610 |
| December 31, 2018 | 2.255 |
| September 30, 2018 | 1.921 |
| June 30, 2018 | 1.552 |
| March 31, 2018 | 6.049 |
| December 31, 2017 | 3.223 |
| September 30, 2017 | 4.008 |
| June 30, 2017 | 2.834 |
| March 31, 2017 | 1.955 |
| December 31, 2016 | 6.104 |
| September 30, 2016 | 3.556 |
| June 30, 2016 | 2.560 |
| March 31, 2016 | 3.082 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Capricor Therapeutics, Inc. | 0.3698 |
| Ocugen, Inc. | -5.314 |
| CytomX Therapeutics, Inc. | 0.0189 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 85.83M |
| Total Liabilities (Quarterly) | 8.297M |
| Shareholders Equity (Quarterly) | 77.54M |
| Current Ratio | 11.88 |
| Net Debt Paydown Yield | 0.56% |